Assembly Biosciences, Inc.
ASMB · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $38 | $20 | $52 | $46 |
| Short-Term Investments | $74 | $110 | $39 | $101 |
| Receivables | $0 | $0 | $1 | $0 |
| Inventory | $0 | -$3 | $0 | $0 |
| Other Curr. Assets | $3 | $7 | $4 | $7 |
| Total Curr. Assets | $116 | $134 | $97 | $154 |
| Property Plant & Equip (Net) | $3 | $3 | $4 | $7 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $28 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $0 | $1 | $2 |
| Total NC Assets | $4 | $3 | $5 | $37 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $119 | $137 | $102 | $191 |
| Liabilities | – | – | – | – |
| Payables | $1 | $0 | $2 | $3 |
| Short-Term Debt | $0 | $1 | $3 | $3 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $38 | $31 | $0 | $0 |
| Other Curr. Liab. | $9 | $7 | $10 | $10 |
| Total Curr. Liab. | $48 | $39 | $16 | $16 |
| LT Debt | $3 | $1 | $0 | $3 |
| Deferred Rev, NC | $0 | $55 | $0 | $3 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $35 | $0 | $3 | $0 |
| Total NC Liab. | $38 | $57 | $3 | $6 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $3 | $2 | $3 | $6 |
| Total Liabilities | $86 | $96 | $19 | $22 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$826 | -$786 | -$725 | -$631 |
| AOCI | -$0 | -$0 | -$1 | -$0 |
| Other Equity | $859 | $827 | $808 | $801 |
| Total Equity | $33 | $41 | $83 | $169 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $119 | $137 | $102 | $191 |
| Net Debt | -$35 | -$17 | -$49 | -$39 |